Switzerland· 68063001
Raxone, comprimé pelliculé
A idebenone product containing idebenonum, registered in Switzerland by Chiesi SA and dispensed under Swissmedic category B. The same ATC class is registered in 12 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Idebenone is registered in 12 of 19 countries.
Countries holding a registration under ATC N06BX13 (idebenone), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Idebenone · ATC N06BX13
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of idebenone costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Idebenone · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- IT Italy$395.68
The record
At a glance
Swissmedic (Switzerland)- Active substance
- idebenonum
- Manufacturer
- Chiesi SA
- Country
- Switzerland (CH)
- ATC code
- N06BX13
- ATC class
- Idebenone
- Defined daily dose
- 0.9 g, O
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Idebenone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomIdebenone 150mg capsulesSpecial Order
- NorwayIdebenone smart nutritionSmart Nutrition
- FinlandRaxoneChiesi Farmaceutici S.p.A.
- FranceRAXONE 150 mg, comprimé pelliculéCHIESI FARMACEUTICI
- IrelandRaxone 150 mg film-coated tabletsChiesi Farmaceutici S.p.A.
- IcelandRaxoneChiesi Farmaceutici S.p.A.*
- ItalyRAXONE*180 cpr rivestite 150 mg flaconeCHIESI FARMACEUTICI SpA
- NetherlandsRaxone 150 mg filmomhulde tablettenChiesi Farmaceutici S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Iceland · Raxone
- Liechtenstein · Raxone
- Norway · Raxone
- Portugal · Amizal, Cerestabon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7e45a87c-8ed0-4ccb-a2f4-69efd6265b92 GET /v1/drugs/7e45a87c-8ed0-4ccb-a2f4-69efd6265b92?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about idebenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.